Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

SLSN - Solesence, Inc. Latest News | Finranks

Home

SLSN

S

Solesence, Inc. (SLSN)

NCM – Real Time Price. Currency in USD

0.91

-0.03 (-2.99%)

At close: Mar 27, 2026, 4:00 PM EDT

0.91

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:04 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026

ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2025 before the market opens on Tuesday, March 31, 2026, and host a conference call and webcast on the same date.

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoolie Park as Vice President of Brand Partnerships.

Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript

Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript

Solesence, Inc. ( SLSN ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Kevin Cureton - President & CEO Jess Jankowski Laura Riffner - Chief Financial Officer Conference Call Participants Wayne Rowan Ron Richards Presentation Operator Good day, and thank you for standing by. Welcome to the Solesence Third Quarter 2025 Conference Call.

Solésence Reports Third Quarter 2025 Financial Results

Solésence Reports Third Quarter 2025 Financial Results

Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025.

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Company's continued innovation and operational excellence in its new phase of growth.

Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call

Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call

ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2025 before the market opens on Tuesday, November 11, 2025, and host a conference call and webcast on the same date.

Solésence Reports Second Quarter 2025 Financial Results

Solésence Reports Second Quarter 2025 Financial Results

ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025.

Videos

No Data

There is no data to display

Press releases

Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships

Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoolie Park as Vice President of Brand Partnerships.

Solésence Reports Third Quarter 2025 Financial Results

Solésence Reports Third Quarter 2025 Financial Results

Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025.

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Company's continued innovation and operational excellence in its new phase of growth.

Solésence Reports Second Quarter 2025 Financial Results

Solésence Reports Second Quarter 2025 Financial Results

ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025.